74. Ran C, Zhang Z, Hooker J, Moore A (2012) In vivo photoactivation without “light”: use of
Cherenkov radiation to overcome the penetration limit of light. Mol Imaging Biol 14:156–162
75. Thorek DLJ, Ogirala A, Beattie BJ, Grimm J (2013) Quantitative imaging of disease signatures
through radioactive decay signal conversion. Nat Med 19:1345–1350
76. Das S, Haedicke K, Grimm J (2017) Cerenkov-activated sticky tag for in vivo fluorescence
imaging. J Nucl Med 117:198549
77. Spinelli AE, Ferdeghini M, Cavedon C, Zivelonghi E, Calandrino R, Fenzi A, Sbarbati A,
Boschi F (2013) First human Cerenkography. J Biomed Opt 18(2):20502
78. Thorek DL, Riedl CC, Grimm J (2014) Clinical Cerenkov luminescence imaging of
(18)F-FDG. J Nucl Med 55:95–98
79. Hartl BA, Hirschberg H, Marcu L, Cherry SR, Clinic M (2016) Radiation generated from
yttrium-90. J Environ Pathol Toxicol Oncol 35:185–192
80. Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X,
Sudlow G et al (2018) Radionuclides transform chemotherapeutics into phototherapeutics for
precise treatment of disseminated cancer. Nat Commun 9:275
81. Kamkaew A, Cheng L, Goel S, Valdovinos HF, Barnhart TE, Liu Z, Cai W (2016) Cerenkov
radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica
nanoparticles. ACS Appl Mater Interfaces 8(40):26630–26637
82. Goel S, Ferreira CA, Chen F, Ellison PA, Siamof CM, Barnhart TE, Cai W (2018) Activatable
hybrid nanotheranostics for tetramodal imaging and synergistic photothermal/photodynamic
therapy. Adv Mater 30:1–9
The Present and Future of Optical Imaging Technologies in the Clinic:. . .
223
Précédent

- 226/230

Suivant